Diamond Biotechnology Co., Ltd (TPEX:6815)
Taiwan · Delayed Price · Currency is TWD 22.35
+0.25 (1.13%)
Oct 8, 2026, 1:59 PM CST
Diamond Biotechnology Market Cap
Diamond Biotechnology has a market cap or net worth of 897.33 million as of October 8, 2026. It is the 35,603rd most valuable company in the world and the 2,140th biggest in Taiwan. Its market cap has decreased by 60.46% in one year.
Market Cap
897.33M
Enterprise Value
855.49M
Revenue
464.63M
Global Rank
Country Rank
#2,140 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since January 29, 2021, Diamond Biotechnology's market cap has decreased from 1.68B to 897.33M, a decrease of -46.61%. That is a compound annual growth rate of -10.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 897.33M | -64.16% |
| Dec 31, 2025 | 2.50B | -7.50% |
| Dec 31, 2024 | 2.71B | 12.05% |
| Dec 29, 2023 | 2.42B | 179.34% |
| Dec 30, 2022 | 864.86M | -11.33% |
| Dec 30, 2021 | 975.37M | -41.97% |
| Jan 29, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Taiwan Biomaterial | 1.56B |
| AViTA | 1.39B |
| Bioptik Technology Incorporation | 1.30B |
| S&S Healthcare Holding | 1.18B |
| Rossmax International | 1.05B |
| Wiltrom | 958.04M |
| AmCad BioMed | 877.16M |
| Cowealth Medical Holding | 804.59M |